Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration

被引：0
|
作者：
Byung-Jin Ahn
Moon Ki Choi
Young Suk Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
Jae-Wook Ko
Dong-Seok Yim
机构：
[1] Dongguk University,Medical Science Research Center
[2] Sungkyunkwan University School of Medicine,Division of Hematology
[3] Samsung Medical Center,Oncology, Department of Medicine, Samsung Medical Center
[4] The Catholic University of Korea,Department of Clinical Pharmacology & Therapeutics
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Gastric cancer; CPT-11; Intraperitoneal administration; Pharmacokinetics; NONMEM;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1235 / 1245
页数：10
相关论文
共 50 条
  • [11] Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding
    Choi, Moon Ki
    Ahn, Byung-Jin
    Yim, Dong-Seok
    Park, Young Suk
    Kim, Sung
    Sohn, Tae Sung
    Noh, Jae Hyung
    Heo, Jin Seok
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 5 - 11
  • [12] Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients
    Katsuya Makihara
    Sayaka Nakamura
    Kazuyo Miyagi
    Hiroyuki Ueno
    Izumi Nakata
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 527 - 533
  • [13] Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients
    Makihara, Katsuya
    Nakamura, Sayaka
    Miyagi, Kazuyo
    Ueno, Hiroyuki
    Nakata, Izumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 527 - 533
  • [14] Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer
    Sugiyama, T
    Yakushiji, M
    Nishida, T
    Ushijima, K
    Okura, N
    Kigawa, J
    Terakawa, N
    CANCER LETTERS, 1998, 128 (02) : 211 - 218
  • [15] Mobilization of peripheral blood stem cells in patients with advanced thoracic malignancies after irinotecan (CPT-11) administration
    Egusa, Y
    Fujiwara, Y
    Syaharuddin, E
    Sumiyoshi, H
    Isobe, T
    Yamakido, M
    ANTICANCER RESEARCH, 1998, 18 (1B) : 481 - 487
  • [16] Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer
    Takashi Yoshioka
    Yuh Sakata
    Masanori Terashima
    Kouji Sekikawa
    Makio Gamoh
    Yasushi Mitachi
    Soh Saitoh
    Ryunosuke Kanamaru
    Gastric Cancer, 2003, 6 (3) : 153 - 158
  • [17] Pharmacokinetics of irinotecan (CPT-11) in patients treated with neomycin to diminish β-glucuronidase activity in the intestines.
    Sparreboom, A
    Kehrer, D
    Verweij, J
    De Bruijn, P
    De Jonge, MJA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3846S - 3846S
  • [18] Weekly cisplatin (CDDP) plus irinotecan (CPT-11) as first line in patients with advanced gastric cancer (AGC)
    Constenla, Manuel
    Fernandez, Isaura
    Palacios, Patricia
    Arroyo, Fco Ramon G.
    Lorenzo, Isabel
    Salgado, Laura
    Varela, Silvia
    Clemente, Pedro L.
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [19] Irinotecan (CPT-11) in advanced colorectal cancer patients with progression after therapy with 5-FU.
    Mendez, M
    Salud, A
    García, C
    Navalón, M
    España, P
    Cruz, JJ
    Diz, P
    del Val, G
    del Prado, M
    ANNALS OF ONCOLOGY, 2000, 11 : 56 - 56
  • [20] Activity and safety of a low dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin for relapsed gastric cancer patients: a preliminary report
    S. Shimoyama
    F. Aoki
    N. Shimizu
    Y. Tatsutomi
    K. Mafune
    M. Kaminishi
    International Journal of Clinical Oncology, 2003, 8 (1) : 0049 - 0052
12345